Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.015 | 0.7 |